Healthcarenews06 May, 2024Business
The global cardiac marker testing market is expected to grow at a compound annual growth rate (CAGR) of 9.4% from 2023 to 2028, rising from $4.4 billion in 2023 to $6.9 billion by 2028. Increasing Demand for Early Cardiovascular Disease Diagnosis One of the primary drivers is the increasing demand for early diagnosis of cardiovascular diseases like heart attacks and heart failure. Cardiac biomarker tests can detect signs of these conditions early, allowing for timely treatment and improved outcomes. As awareness grows about the importance of early testing, utilization is rising.
Namaste Nola
Hyperrevamp
Myg Future Punalur
Cureus Journal
Ajay Kumar
Bet88
Arun Kumar
Bruus Alstrup
888p
F&s Enterprises